• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Celgene Corp

NASDAQ:CELG

$68.90 -$1.01 (-1.44%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

9 Cash Laden Large Caps With Strong EPS Growth Trends

5/25/2012 by Seeking Alpha

Insiders Buying Shares In These 3 High-Growth Drug Stocks, Plus 2 Other Noteworthy Sells

5/25/2012 by Seeking Alpha

Cramer's Lightning Round - Titan Is In-Your-Face Optimistic (5/23/12)

5/24/2012 by Seeking Alpha

Orbimed's $3.4B Filing: 2 Stocks It And Other Healthcare Funds Bought In Q1, And Other Trades

5/24/2012 by Seeking Alpha

4-Star Stocks Poised to Pop: Celgene

5/16/2012 by DailyFinance

Celgene Retains Neutral Rec - Analyst Blog

5/14/2012 by Nasdaq

FDA: Celgene Drug Revlimid Increases Risk Of Certain New Cancers

5/7/2012 by Smart Money

FDA Panel to Review Onyx Drug - Analyst Blog

5/7/2012 by Nasdaq

TIP SHEET: Janus Fund Tries To Manage Risk Of Drug Stocks

4/26/2012 by Smart Money

Stocks to watch Thursday: Watson, Teradyne, Crocs

4/26/2012 by MarketWatch

Celgene 1Q Profit Rose 57% On Sales Growth; Plans Venture With Epizyme

4/26/2012 by Smart Money

Pharma & Biotech Stock Outlook - April 2012 - Industry Outlook

4/26/2012 by Nasdaq

Celgene Misses, Reaffirms - Analyst Blog

4/26/2012 by Nasdaq

TIP SHEET: Janus Fund Tries To Manage Risk Of Drug Stocks

4/25/2012 by Smart Money

Amgen Kicks Off Week of Big Biotech Earnings

4/24/2012 by Minyanville

Earnings Preview: Celgene - Analyst Blog

4/24/2012 by Nasdaq

U.S. stock gains hinge on Apple, blue-chip results

4/21/2012 by MarketWatch

MARKET SNAPSHOT: U.S. Stock Gains Hinge On Apple, Blue-chip Results

4/21/2012 by Smart Money

Make Money in 100 Dynamic Nasdaq Stocks the Easy Way

4/18/2012 by DailyFinance

Has Celgene Become the Perfect Stock?

4/16/2012 by DailyFinance

Does Amgen Pass Buffett's Test?

4/15/2012 by DailyFinance

Top Analyst Upgrades & Downgrades (AAPL, CELG, CLD, CNX, DRQ, EIX, NOK, PPL, LEN, PHM, TOL)

4/13/2012 by 247wallst

Drug Executives Tout R&D Spending As Industry Hits Patent Cliff

4/12/2012 by Smart Money

Minyanville's T3 Morning Market Call: Eyes Turn to Earnings Season

4/10/2012 by Minyanville

How to Play Defense Using Growth Stocks

4/5/2012 by Minyanville

This Cancer Drug Works, but Indication Drama Remains

3/30/2012 by DailyFinance

Small and Wildly Successful Hedge Funds Love These 10 Stocks

3/20/2012 by DailyFinance

Will Celgene Help You Retire Rich?

3/19/2012 by DailyFinance

Drug Pricing Takes This Biotech on a Rollercoaster

3/16/2012 by DailyFinance

Top Analyst Upgrades & Downgrades (AMD, AIXG, CELG, DNDN, DLR, EBAY, ICE, JOY, LVLT, NSC, RSH, BOX,

3/15/2012 by 247wallst

24/7 Wall St. Closing Bell (NSC, DNDN, EBAY, CELG, DLR, AXAS, AMCX, CATO, E, FF, ROST, TA, CLWT, TWE

3/15/2012 by 247wallst

The 10 Best Stocks of the Past 20 Years

3/12/2012 by Smart Money

Celgene Cut to Neutral - Analyst Blog

3/12/2012 by Nasdaq

Has Spectrum Pharmaceuticals Become the Perfect Stock?

3/9/2012 by DailyFinance

This Drugmaker Is Covering All Its Bills

3/2/2012 by DailyFinance

Onyx Pharma's MM Candidate Advances - Analyst Blog

2/29/2012 by Nasdaq

Buy, Sell, or Hold: Keryx Pharmaceuticals

2/23/2012 by DailyFinance

Still Bullish on Celgene - Analyst Blog

2/16/2012 by Nasdaq

Top Analyst Upgrades & Downgrades (ALTR, AMSC, BIIB, CELG, COH, CSTR, COP, FSLR, GILD, HAIN, MA, RF,

2/10/2012 by 24/7 Wall St.

3 Biotechnology Stocks for Short-Term Traders

2/9/2012 by Nasdaq
See More Articles...